Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide

被引：0
|
作者：
Jonas Kildegaard
Stephen T. Buckley
Rasmus H. Nielsen
Gro K. Povlsen
Torben Seested
Ulla Ribel
Helle B. Olsen
Svend Ludvigsen
Claus B. Jeppesen
Hanne H. F. Refsgaard
Kristian M. Bendtsen
Niels R. Kristensen
Susanne Hostrup
Jeppe Sturis
机构：
[1] Novo Nordisk A/S,
来源：
Pharmaceutical Research | 2019年 / 36卷
关键词：
absorption; fast-acting insulin aspart; niacinamide; oligomerization; vasodilation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
    Hoevelmann, Ulrike
    Heise, Tim
    Nosek, Leszek
    Sassenfeld, Bettina
    Thomsen, Karen Margrete Due
    Haahr, Hanne
    CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 503 - 509
  • [22] Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
    Ulrike Hövelmann
    Tim Heise
    Leszek Nosek
    Bettina Sassenfeld
    Karen Margrete Due Thomsen
    Hanne Haahr
    Clinical Drug Investigation, 2017, 37 : 503 - 509
  • [23] SUBCUTANEOUS ABSORPTION OF FAST-ACTING INSULIN ANALOGS - KINETICS AND BIOEFFECTIVENESS
    RADZIUK, J
    DAVIES, J
    PYE, S
    DIMARCHI, R
    SHIELDS, J
    CHANCE, R
    DIABETOLOGIA, 1992, 35 : A3 - A3
  • [24] KINETICS OF SUBCUTANEOUS ABSORPTION AND BIOEFFECTIVENESS OF FAST-ACTING INSULIN ANALOGS
    RADZIUK, J
    DAVIES, J
    PYE, S
    DIMARCHI, RD
    SHIELDS, JE
    CHANCE, RE
    DIABETES, 1993, 42 : A205 - A205
  • [25] Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes
    Raskin, P
    Riis, A
    Guthrie, RA
    Jovanovic, L
    Leiter, L
    DIABETES CARE, 2000, 23 (05) : 583 - 588
  • [26] Efficacy and safety of fast-acting insulin aspart in adults with type 2 diabetes with different insulin requirements
    Sesti, G.
    Lane, W.
    Ekelund, M.
    Thorisdottir, O.
    Jodar, E.
    Oviedo, A.
    Rathor, N.
    Senior, P.
    Franek, E.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S330 - S330
  • [27] Performance of Fast-Acting Aspart Insulin as Compared to Aspart Insulin in Insulin Pump for Managing Type 1 Diabetes Mellitus: A Meta-Analysis
    Dutta, Deep
    Mohindra, Ritin
    Mahajan, Kunal
    Sharma, Meha
    DIABETES & METABOLISM JOURNAL, 2023, 47 (01) : 72 - 81
  • [28] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both with insulin degludec with or without metformin, in adults with type 2 diabetes
    Lane, W.
    Bozkurt, K.
    Favaro, E.
    Jang, H. C.
    Kjaersgaard, M. I. S.
    Oviedo, A.
    Rose, L.
    Senior, P.
    Sesti, G.
    Soto Gonzalez, A.
    Franek, E.
    DIABETOLOGIA, 2019, 62 : S10 - S11
  • [29] Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes
    Bowering, K.
    Harvey, J.
    Kolaczynski, J. W.
    Snyder, J. W.
    Bode, B. W.
    DIABETIC MEDICINE, 2019, 36 (06) : 771 - 775
  • [30] Hypoglycemia with Mealtime Fast-Acting Insulin Aspart vs. Insulin Aspart Across Two Large Type 1 Diabetes Trials
    De Block, Christophe
    Carlson, Anders
    Rose, Ludger
    Gondolf, Theis
    Gorst-Rasmussen, Anders
    Lane, Wendy
    DIABETES, 2018, 67
12345